Raub Brock Capital Management LP Sells 501 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Raub Brock Capital Management LP lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,236 shares of the healthcare conglomerate’s stock after selling 501 shares during the period. UnitedHealth Group comprises approximately 3.8% of Raub Brock Capital Management LP’s holdings, making the stock its 14th largest holding. Raub Brock Capital Management LP’s holdings in UnitedHealth Group were worth $18,848,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in UNH. Buckingham Capital Management Inc. increased its position in shares of UnitedHealth Group by 1.4% during the first quarter. Buckingham Capital Management Inc. now owns 25,283 shares of the healthcare conglomerate’s stock valued at $12,508,000 after acquiring an additional 337 shares in the last quarter. Triangle Securities Wealth Management boosted its stake in shares of UnitedHealth Group by 1.7% in the 1st quarter. Triangle Securities Wealth Management now owns 4,177 shares of the healthcare conglomerate’s stock worth $2,066,000 after buying an additional 70 shares during the last quarter. Johnson & White Wealth Management LLC lifted its holdings in UnitedHealth Group by 4.9% in the first quarter. Johnson & White Wealth Management LLC now owns 1,532 shares of the healthcare conglomerate’s stock valued at $758,000 after acquiring an additional 71 shares during the period. BTC Capital Management Inc. bought a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $7,827,000. Finally, Cardano Risk Management B.V. lifted its stake in shares of UnitedHealth Group by 4.0% in the 1st quarter. Cardano Risk Management B.V. now owns 200,595 shares of the healthcare conglomerate’s stock worth $99,234,000 after purchasing an additional 7,626 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

NYSE UNH opened at $569.61 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $525.99 billion, a P/E ratio of 37.77, a P/E/G ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The firm’s fifty day simple moving average is $584.42 and its two-hundred day simple moving average is $533.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the firm posted $6.56 EPS. The firm’s revenue was up 9.2% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.47%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is 55.70%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday. Cantor Fitzgerald lifted their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday. KeyCorp started coverage on UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday. Finally, Truist Financial reissued a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday. Three research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $615.58.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.